{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:45:53Z","timestamp":1788911153288,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T00:00:00Z","timestamp":1468195200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11926-016-0603-y","type":"journal-article","created":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T05:23:26Z","timestamp":1468214606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Juvenile Spondyloarthropathies"],"prefix":"10.1007","volume":"18","author":[{"given":"Amra","family":"Adrovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenan","family":"Barut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezgin","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Kasapcopur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,11]]},"reference":[{"key":"603_CR1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrrheum.2012.37","volume":"8","author":"SML Tse","year":"2012","unstructured":"Tse SML, Laxer RM. New advances in juvenile spondyloarthritis. Nat Rev Rheumatol. 2012;8:269\u201379. An up-to date review of advances in the classification, diagnosis and management strategies for juvenile spondyloarthritis.","journal-title":"Nat Rev Rheumatol"},{"key":"603_CR2","volume-title":"Juvenile-onset Spondyloarthropathies. Current Options in Pediatric Rheumatology. A guide for general practitioners and pediatricians","author":"O Kasapcopur","year":"2006","unstructured":"Kasapcopur O, Ayaz AN, Apelyan M, Ozdogan H, Arisoy N. Juvenile-onset Spondyloarthropathies. Current Options in Pediatric Rheumatology. A guide for general practitioners and pediatricians. New York: Nova Science Publisher; 2006."},{"key":"603_CR3","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"603_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/ard.2008.097774","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68:1\u201344. Fundamental manuscript on the most relevant aspects for the assessment of spondyloarthritis.","journal-title":"Ann Rheum Dis"},{"key":"603_CR5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00296-004-0460-2","volume":"25","author":"O Kasapcopur","year":"2004","unstructured":"Kasapcopur O, Demirli N, Ozdogan H, Apelyan M, Caliskan S, Sever L, et al. Evaluation of classification criteria for juvenile-onset spondyloarthropathies. Rheumatol Int. 2004;25:414\u20138.","journal-title":"Rheumatol Int"},{"key":"603_CR6","first-page":"1981","volume":"23","author":"PN Malleson","year":"1996","unstructured":"Malleson PN, Fung MY, Rosenberg AM. The incidence of pediatric rheumatic diseses: results from the Canadian pediatric rheumatology association disease registry. J Rheumatol. 1996;23:1981\u20137.","journal-title":"J Rheumatol"},{"key":"603_CR7","first-page":"745","volume":"22","author":"K Oen","year":"1995","unstructured":"Oen K, Fast M, Postl BL. Epidemiology of juvenile rheumatoid arthritis in Manitoba, Canada: cycles in incidence. J Rheumatol. 1995;22:745\u201350.","journal-title":"J Rheumatol"},{"key":"603_CR8","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.3899\/jrheum.120642","volume":"39","author":"PF Weiss","year":"2012","unstructured":"Weiss PF, Beukelman T, Schanberg LE, Kimura Y, Colbert RA. CARRA Registry Investigators Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: the Childhood Arthritis and Rheumatology Research Alliance Registry. J Rheumatol. 2012;39:2341\u201351.","journal-title":"J Rheumatol"},{"key":"603_CR9","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3899\/jrheum.120110","volume":"39","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Ringold S, Davis TE, DeWitt EM, Pelajo CF, Weiss PF, et al. Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the\u00a0CARRA\u00a0Registry. J Rheumatol. 2012;39:1867\u201374.","journal-title":"J Rheumatol"},{"key":"603_CR10","first-page":"1035","volume":"41","author":"O Kasap\u00e7opur","year":"2004","unstructured":"Kasap\u00e7opur O, Yologlu N, Ozyazgan Y, Ercan G, Caliskan S, Sever L, et al. Uveitis and anti nuclear antibody positivity in children with juvenile idiopathic arthritis. Indian Pediatr. 2004;41:1035\u20139.","journal-title":"Indian Pediatr"},{"key":"603_CR11","first-page":"431","volume":"9","author":"H Ozdogan","year":"1991","unstructured":"Ozdogan H, Kasapcopur O, Dede H, Arisoy N, Beceren T, Yurdakul S, et al. Juvenile chronic arthritis in a Turkish population. Clin Exp Rheumatol. 1991;9:431\u20135.","journal-title":"Clin Exp Rheumatol"},{"key":"603_CR12","first-page":"111","volume":"29","author":"E Demirkaya","year":"2011","unstructured":"Demirkaya E, Ozen S, Bilginer Y, Ayaz N, Makay B, Unsal E, et al. The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association. Clin Exp Rheumatol. 2011;29:111\u20136. A relevant cross-sectional study of demographics, clinical and laboratory features and subtype distribution of juvenile idiopathic arthritis in an eastern Mediterranean country, based on a multicenter registry.","journal-title":"Clin Exp Rheumatol"},{"key":"603_CR13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrrheum.2012.41","volume":"8","author":"JD Reveille","year":"2012","unstructured":"Reveille JD. Genetics of spondyloarthritis beyond the MHC. Nat Rev Rheumatol. 2012;8:296\u2013304.","journal-title":"Nat Rev Rheumatol"},{"key":"603_CR14","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s10067-015-3029-4","volume":"34","author":"A Aggarwal","year":"2015","unstructured":"Aggarwal A, Misra DP. Enthesitis-related arthritis. Clin Rheumatol. 2015;34:1839\u201346. Brief description of the pathogenesis, clinical features and treatment options for enthesitis-related arthritis.","journal-title":"Clin Rheumatol"},{"key":"603_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrrheum.2013.191","volume":"10","author":"P Jacques","year":"2014","unstructured":"Jacques P, Elewaut D. Gut inflammation in SpA: flagellin joins the dance? Nat Rev Rheumatol. 2014;10:5\u20136.","journal-title":"Nat Rev Rheumatol"},{"key":"603_CR16","doi-asserted-by":"crossref","unstructured":"Sezen M, Barut K, A\u00e7\u0131kel C, Kasapcopur O. The new proposal classification criteria for juvenile spondyloarthropathies [abstract]. Arthritis Rheumatol. 2014;66:S1004(2301) (suppl 10).","DOI":"10.1186\/1546-0096-12-S1-P45"},{"key":"603_CR17","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","volume":"377","author":"M Dougados","year":"2011","unstructured":"Dougados M, Baeten D. Spondyloarthritis. Lancet. 2011;377:2127\u201337.","journal-title":"Lancet"},{"key":"603_CR18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit M, van der Heijde D, Landewe R, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011;70:25\u201331. Comparison of The Assessment of Spondylo Arthritis International Societ (ASAS) classification criteria with the European Spondylarthropathy Study Group (ESSG) and Amor criteria which shows that the new ASAS classification criteria for peripheral SpA performed well in patients presenting with peripheral arthritis, enthesitis and\/or dactylitis.","journal-title":"Ann Rheum Dis"},{"key":"603_CR19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777\u201383. ASAS report that validates and refines two sets of criteria for the classification and diagnosis of axial spondyloarthritis.","journal-title":"Ann Rheum Dis"},{"key":"603_CR20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1546-0096-10-14","volume":"10","author":"R Burgos-Vargas","year":"2012","unstructured":"Burgos-Vargas R. The assessment of the spondyloarthritis international society concept and criteria for the classification of axial spondyloarthritis and peripheral spondyloarthritis: a critical appraisal for the pediatric rheumatologist. Pediatr Rheumatol. 2012;10:14. Excellent assessment of the spondyloarthritis international society concept and criteria for the classification of axial spondyloarthritis and peripheral spondyloarthritis with a special emphasis on the pediatric population.","journal-title":"Pediatr Rheumatol"},{"key":"603_CR21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.rbr.2014.06.005","volume":"54","author":"AP Duartea","year":"2014","unstructured":"Duartea AP, Marquesa CDL, Bortoluzzob AB, Goncalvesc CR, da Silvad JA B, Ximenese AC, et al. Epidemiologic profile of juvenile-onset compared to adult-onset spondyloarthritis in a large Brazilian cohort. Rev Bras Reumatol. 2014;54:424\u201330. Prospective, multicenter analysis of a large Brazilian cohort with 1424 patients with the diagnosis of SpA revealing the main differences among juvenile-onset and adult-onset spondyloarthritis patients.","journal-title":"Rev Bras Reumatol"},{"key":"603_CR22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/art.21174","volume":"53","author":"M Stone","year":"2005","unstructured":"Stone M, Warren RW, Bruckel J, Cooper D, Cortinovis D, Inman RD, et al. Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis. Arthritis Rheum. 2005;53:445\u201351.","journal-title":"Arthritis Rheum"},{"key":"603_CR23","first-page":"691","volume":"27","author":"C Alvarez-Madrid","year":"2009","unstructured":"Alvarez-Madrid C, Merino R, Inocencio JD, Garcia-Consuegra J. Tarsitis as an initial manifestation of juvenile spondyloarthropathy. Clin Exp Rheumatol. 2009;27:691\u20134.","journal-title":"Clin Exp Rheumatol"},{"issue":"suppl 2","key":"603_CR24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/annrheumdis-2015-eular.6017","volume":"74","author":"K Barut","year":"2015","unstructured":"Barut K, Sezen M, Sahin S, Adrovic A, Ugurlu S, Ozdogan H, et al. Juvenile Spondyloarthropathies: a Single Center Experience [abstract]. Ann Rheum Dis. 2015;74 suppl 2:390.","journal-title":"Ann Rheum Dis"},{"key":"603_CR25","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","volume":"68","author":"D Heijde van der","year":"2009","unstructured":"van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, et al. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis. 2009;68:1811\u20138.","journal-title":"Ann Rheum Dis"},{"key":"603_CR26","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/acr.22411","volume":"66","author":"PF Weiss","year":"2014","unstructured":"Weiss PF, Colbert RA, Xiao R, Feudtner C, Beukelman T, Dewitt EM, et al. Development and retrospective validation of the juvenile spondyloarthritis disease activity index. Arthritis Care Res. 2014;66:1775\u201382.","journal-title":"Arthritis Care Res"},{"key":"603_CR27","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/art.22709","volume":"56","author":"RK Saurenmann","year":"2007","unstructured":"Saurenmann RK, Rose JB, Tyrrell P, Feldman BM, Laxer RM, Schneider R, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum. 2007;56:1974\u201384.","journal-title":"Arthritis Rheum"},{"key":"603_CR28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12969-016-0069-5","volume":"14","author":"LA Henderson","year":"2016","unstructured":"Henderson LA, Zurakowski D, Angeles-Han ST, Lasky A, Rabinovich CE, Lo MS, et al. Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry. Pediatr Rheumatol Online J. 2016;14:9.","journal-title":"Pediatr Rheumatol Online J"},{"key":"603_CR29","first-page":"152","volume":"70","author":"P Kahn","year":"2012","unstructured":"Kahn P. Juvenile idiopathic arthritis. An update for the clinican. Bull NYU Hosp Jt Dis. 2012;70:152\u201366.","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"603_CR30","first-page":"727","volume":"20","author":"R Burgos-Vargas","year":"2002","unstructured":"Burgos-Vargas R, Pacheco-Tena C, Vazquez-Mellado J. A short-term follow-up of enthesitis and arthritis in the active phase of juvenile onset spondyloarthropathies. Clin Exp Rheumatol. 2002;20:727\u201331.","journal-title":"Clin Exp Rheumatol"},{"key":"603_CR31","first-page":"2055","volume":"35","author":"L Berntson","year":"2008","unstructured":"Berntson L, Damgard M, Andersson-Gare B, Herlin T, Nielsen S, Nordal E, et al. HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis. J Rheumatol. 2008;35:2055\u201361.","journal-title":"J Rheumatol"},{"key":"603_CR32","first-page":"602","volume":"33","author":"A Saraux","year":"2015","unstructured":"Saraux A, Benichou J, Guillevin L, Idbrik L, Job-Deslandre C, Sibilia J, et al. Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive\u00a0TNF-\u03b1 antagonists in France?The CORPUS cohort study. Clin Exp Rheumatol. 2015;33:602\u201310.","journal-title":"Clin Exp Rheumatol"},{"key":"603_CR33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.bor.0000129717.19777.9d","volume":"16","author":"PS Helliwell","year":"2004","unstructured":"Helliwell PS. Relationship of psoriatic arthritis with the other spondyloarthropathies. Curr Opin Rheumatol. 2004;16:344\u20139.","journal-title":"Curr Opin Rheumatol"},{"key":"603_CR34","first-page":"40","volume":"33","author":"A Ravelli","year":"2015","unstructured":"Ravelli A, Consolaro A, Schiappapietra B, Martini A. The conundrum of juvenile psoriatic arthritis. Clin Exp Rheumatol. 2015;33:40\u20133. A worthy manuscript which debates discordances in the definition and classification of juvenile psoriatic arthritis.","journal-title":"Clin Exp Rheumatol"},{"key":"603_CR35","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665\u201373.","journal-title":"Arthritis Rheum"},{"key":"603_CR36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/acr.22201","volume":"66","author":"K Vendhan","year":"2014","unstructured":"Vendhan K, Sen D, Fisher C, Ioannou Y, Hall-Cragg MA. Inflammatory changes of the lumbar spine in children and adolescents with enthesitis-related arthritis: magnetic resonance imaging findings. Arthritis Care Res. 2014;66:40\u20136. A considerable description of magnetic resonance imaging of lumbar spine abnormalities in a cohort of patients with enthesitis-related arthritis compared to a control group of adolescents with mechanical back pain.","journal-title":"Arthritis Care Res"},{"key":"603_CR37","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s10067-010-1514-3","volume":"29","author":"MH Yilmaz","year":"2010","unstructured":"Yilmaz MH, Ozbayrak M, Kasapcopur O, Kurugoglu S, Kanberoglu K. Pelvic MRI findings of juvenile-onset ankylosing spondylitis. Clin Rheumatol. 2010;29:1007\u201313.","journal-title":"Clin Rheumatol"},{"key":"603_CR38","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/art.39159","volume":"67","author":"PF Weiss","year":"2015","unstructured":"Weiss PF, Xiao R, Biko DM, Johnson AM, Chauvin NA. Detection of inflammatory sacroiliitis in children with magnetic resonance imaging: is gadolinium contrast enhancement necessary? Arthritis Rheumatol. 2015;67:2250\u20136.","journal-title":"Arthritis Rheumatol"},{"key":"603_CR39","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3899\/jrheum.100090","volume":"37","author":"I Pagnini","year":"2010","unstructured":"Pagnini I, Savelli S, Matucci-Cerinic M, Fonda C, Cimaz R, Simonini G. Early predictors of juvenile sacroiliitis in enthesitis-related arthritis. J Rheumatol. 2010;37:2395\u2013401.","journal-title":"J Rheumatol"},{"key":"603_CR40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"T Beukelman","year":"2011","unstructured":"Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, et al. 2011\u00a0American College of\u00a0Rheumatology\u00a0recommendations for the treatment of juvenile idiopathic\u00a0arthritis: initiation and safety monitoring of therapeutic agents for the treatment of\u00a0arthritis\u00a0and systemic features. Arthritis Care Res (Hoboken). 2011;63:465\u201382.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"603_CR41","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/rheumatology\/ket407","volume":"53","author":"JE Paramarta","year":"2014","unstructured":"Paramarta JE, Baeten D. Spondyloarthritis: from unifying concepts to improved treatment. Rheumatology (Oxford). 2014;53:1547\u201359.","journal-title":"Rheumatology (Oxford)"},{"key":"603_CR42","doi-asserted-by":"crossref","first-page":"R230","DOI":"10.1186\/ar4072","volume":"24","author":"G Horneff","year":"2012","unstructured":"Horneff G, Fitter S, Foeldvari I, Minden K, Kuemmerle-Deschner J, Tzaribacev N, et al. Double-blind, placebocontrolled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement. Arthritis Res Ther. 2012;24:R230.","journal-title":"Arthritis Res Ther"},{"key":"603_CR43","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/art.23606","volume":"58","author":"H Haibel","year":"2008","unstructured":"Haibel H, Rudwaleit M, Listing J, Heldmann F, Wong RL, Kupper H, et al. Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two. Arthritis Rheum. 2008;58:1981\u201391.","journal-title":"Arthritis Rheum"},{"key":"603_CR44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/annrheumdis-2012-203201","volume":"73","author":"J Sieper","year":"2014","unstructured":"Sieper J, Lenaerts J, Wollenhaupt J, Rudwaleit M, Mazurov VI, Myasoutova L, et al. Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1. Ann Rheum Dis. 2014;73:101\u20137.","journal-title":"Ann Rheum Dis"},{"key":"603_CR45","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1136\/ard.2007.073098","volume":"67","author":"M Rudwaleit","year":"2008","unstructured":"Rudwaleit M, Schwarzlose S, Hilgert ES, Listing J, Braun J, Sieper J. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis. 2008;67:1276\u201381.","journal-title":"Ann Rheum Dis"},{"key":"603_CR46","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/acr.22330","volume":"66","author":"F Canoui Poitrine","year":"2014","unstructured":"Canoui Poitrine F, Poulain C, Molto A, Le T, Lafon C, Farrenq V, et al. Early tumor necrosis factor-antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: results from a prospective multicenter French cohort. Arthritis Care Res (Hoboken). 2014;66:1395\u2013402. Data from a French prospective observational study that underlines the importance of early diagnosis and treatment of axial spondyloarthritis in order to achieve the best improvement of patient symptoms. Furthermore, it defines factors associated with early anti-TNF alpha initiation.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"603_CR47","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","volume":"382","author":"D Baeten","year":"2013","unstructured":"Baeten D, Sieper J, Braun J, Sieper J, Emery P, van der Heijde D. Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2013;382:1705\u201313.","journal-title":"Lancet"},{"key":"603_CR48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/annrheumdis-2012-202646","volume":"73","author":"IB McInnes","year":"2014","unstructured":"McInnes IB, Sieper J, Braun J, Emery P, van der Heijde D, Isaacs JD. Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-tosevere psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-ofconcept trial. Ann Rheum Dis. 2014;73:349\u201356.","journal-title":"Ann Rheum Dis"},{"key":"603_CR49","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(09)60140-9","volume":"373","author":"A Gottlieb","year":"2009","unstructured":"Gottlieb A, Menter A, Mendelsohn A, Shen YK, Li S, Guzzo C, et al. Ustekinumab, a human interleukin 12\/23 monoclonal antibody, for psoriatic arthritis: randomised, doubleblind, placebo controlled, crossover trial. Lancet. 2009;373:633\u201340.","journal-title":"Lancet"},{"key":"603_CR50","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0140-6736(13)60594-2","volume":"31","author":"IB McInnes","year":"2013","unstructured":"McInnes IB, Kavanaugh A, Gottlieb AB, Puig L, Rahman P, Ritchlin C, et al. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. Lancet. 2013;31:780\u20139.","journal-title":"Lancet"},{"key":"603_CR51","first-page":"424","volume":"32","author":"B Hugle","year":"2014","unstructured":"Hugle B, Burgos-Vargas R, Inman RD, O\u2019Shea F, Laxer RM, Stimec J, et al. Long-term outcome of anti-tumour necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis. Clin Exp Rheumatol. 2014;32:424\u201331. An observational study of 16 patients with JSpA from 3 centers that describes long-term efficacy of anti-TNF treatment in JSpA refractory to standard therapy.","journal-title":"Clin Exp Rheumatol"},{"key":"603_CR52","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/acr.22500","volume":"67","author":"D Jadon","year":"2015","unstructured":"Jadon D, Shaddick G, Jobling A, Ramanan AV, Sengupta R. Clinical outcomes and progression to orthopedic surgery in juvenile versus adult onset ankylosing spondylitis. Arthritis Care Res (Hoboken). 2015;67:651\u20137.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"603_CR53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/ard.2009.111260","volume":"69","author":"FH Prince","year":"2010","unstructured":"Prince FH, Geerdink LM, Borsboom GJ, Twilt M, van Rossum MA, Hoppenreijs EP, et al. Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis. Ann Rheum Dis. 2010;69:138\u201342.","journal-title":"Ann Rheum Dis"},{"key":"603_CR54","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2007.069484","volume":"67","author":"V Gerloni","year":"2008","unstructured":"Gerloni V, Pontikaki I, Gattinara M, Fantini F. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients. Ann Rheum Dis. 2008;67:1145\u201352.","journal-title":"Ann Rheum Dis"},{"key":"603_CR55","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3899\/jrheum.120164","volume":"39","author":"R Conway","year":"2012","unstructured":"Conway R, O'shea FD. Juvenile versus adult-onset ankylosing spondylitis: are we comparing apples and oranges? J Rheumatol. 2012;39:887\u20139.","journal-title":"J Rheumatol"},{"key":"603_CR56","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/art.21121","volume":"52","author":"SM Tse","year":"2005","unstructured":"Tse SM, Burgos-Vargas R, Laxer RM. Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy. Arthritis Rheum. 2005;52:2103\u20138.","journal-title":"Arthritis Rheum"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-016-0603-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-016-0603-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-016-0603-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T22:49:20Z","timestamp":1656802160000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-016-0603-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,11]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["603"],"URL":"https:\/\/doi.org\/10.1007\/s11926-016-0603-y","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,11]]},"article-number":"55"}}